The global Drug Delivery Technologies market was valued at US$ US$xx bn in 2020 and is projected to grow at a CAGR of xx% during the forecast period 2021-2031. The rising geriatric population, increasing prevalence of infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, and other diseases is a major driver propelling the market growth. Growing clinical advantages of advanced drug delivery system, rising R&D investments by biopharmaceutical companies, and developing healthcare infrastructure in emerging economies are some of the major factors that boost the Global Drug Delivery Technologies market.
How has COVID-19 had a significant negative impact on the Drug Delivery Technologies Market?
The COVID-19 pandemic has a significant negative impact on the Drug Delivery Technologies drug market globally. The COVID-19 outbreak in 2020 led to international border controls, country-wide lockdowns, pharmaceutical manufacturing restrictions & limitations. This pandemic has hampered the production and distribution of Drug Delivery Technologies.
COVID-19 would undoubtedly have an effect on chronic and infectious diseases patients and their care for the near future. Creating support networks for physicians and patients will help to break down walls and provide patients with appropriate access to potentially life-saving services.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
How this Report Will Benefit you?
Our 530+ page report provides 356 tables and 352 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the global Drug Delivery Technologies market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for Drug Delivery Technologies. Get the financial analysis of the overall market and different segments including drug class, indication, patient demographics, end-user, and distribution channel and capture higher market share. We believe that high opportunity remains in this fast-growing inflammatory bowel disease drugs market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report would help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.
What are the current market drivers?
Rise in consumption of drugs is expected to propel the demand for advanced drug delivery technology. According to the WHO, the prevalence of chronic illness cases is expected to increase by 57%, with higher illness cases in low- & middle-income nations. Additionally, the outbreak of pandemics in the current & past such as COVID19, SARS, Ebola, MERS, and H1N1 have added to the upsurge in drug consumption and vaccination.
Usage convenience and cost-effectiveness of drug delivery technology further driver the market adoption. Pharmaceutical companies like Pfizer, Roche, Novartis, GSK, and BDC are constantly investing in development of drug delivery systems to enhance the oral bioavailability of novel medicines using varied excipients. Also, the rising number of patients with chronic diseases along with growing healthcare awareness is projected to boost the demand for Drug Delivery Technologies.
Where are the market opportunities?
Rising adoption of self-administrative drug delivery methods is gaining popularity. Technological advantages are supporting the development of drug delivery methods that are easily understood and conveniently used by patients without constant supervision of medical practitioner. So, drug makers are drifting from conventional drug delivery techniques to the innovative and enhanced delivery techniques, thereby improving the drug solubility, dispersion, and targeting within the patient.
Escalating investments in drug development are creating opportunities for biopharmaceutical companies to innovate novel drug delivery techniques that offer higher solubility of drugs with self-administration. For increasing the efficacy of novel drugs, the companies develop the transportation system as well, which encourages the private and the public funding agencies to invest in research of drug delivery system. In 2020, Novus Therapeutics, entered into a second phase for clinical trial for its OP0201 product. The drug is developed is combination of surfactant molecule and nasal aerosol technique device.
Competitive Landscape
The major players operating in the inflammatory bowel disease drugs market are Novartis AG, Gilead Sciences, Inc., GlaxoSmithKline, Pfizer Inc., F. Hoffmann-La Roche AG, Johnson & Johnson , Kindeva Drug Delivery, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim, Amgen Inc., Bristol Myers Squibb, Sanofi , Becton, Dickinson and Company (BD), Bayer AG
These leading players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new drugs launch. For instance, August 2020, Johnson entered into strategic acquisition of Momenta Pharmaceuticals, Inc. (Momenta) to expand portfolio of its novel treatment for autoimmune illness application.
'
1. Report Overview
1.1 Introduction to Drug Delivery Technologies Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Reports
1.9 About
2 Executive Summary
3 Market Dynamics
3.1 Drivers for Drug Delivery Technologies Market
3.1.1 Increasing Demand for Pharmaceuticals
3.1.2 Adoption of Advanced Drug Delivery System is projected to boost the Market Growth
3.1.3 Increasing Geriatric Population around the World is Boosting the Demand for Drug Delivery Technologies
3.1.4 Investing In Modern Drug Delivery Technology by Players To Maximise the Revenue Share in the Market
3.2 Restraints for Drug Delivery Technologies Market
3.2.1 Stringent Regulations Associated with Product Launch Hinders the Market Growth
3.2.2 Risk of Injuries Due To Needle Stick Delivery System & Poor Efficiency
3.3 Opportunities for Drug Delivery Technologies Market
3.3.1 Adoption of Self-Administrative Drug Delivery Methods is Gaining Popularity
3.3.2 Rising Awareness and Adoption for Quality Medical Treatment Due To Rising Disposable Income
3.3.3 Rising Public-Private Funding For Development, Expansion And Adoption Of Novel Drug Delivery Technologies
3.4 Trends for Drug Delivery Technologies Market
3.4.1 Outbreak of COVID-19 Pandemic
3.4.2 Reducing the Environmental Impact with Technology Advancements in Drug Delivery Technology
3.4.3 Developing Connected Drug Delivery Systems With Remote Access
3.5 SWOT Analysis for Drug Delivery Technologies Market
3.5.1 Strengths: Drug Delivery Technologies Market
3.5.1.1 Rising Need for Effective Drugs’ Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weaknesses: Drug Delivery Technologies Market
3.5.2.1 Financial Loss Due To Innovative Drug Delivery Technology Failure Has Been a Perennial Problem
3.5.3 Opportunities: Drug Delivery Technologies Market
3.5.3.1 Increase in Number of Collaborations between Biopharmaceutical Companies
3.5.4 Threats: Drug Delivery Technologies Market
3.5.4.1 Adverse-Drug Reactions and Drug Delivery-Based Injuries could Limit the Adoption of Drugs
3.6 Porter’s Five Forces Analysis: Drug Delivery Technologies Market
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyer: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis: Drug Delivery Technologies Market
3.7.1 Political Factors Impacting Drug Delivery Technologies Market
3.7.2 Economic Factors Impacting Drug Delivery Technologies Market
3.7.3 Social Factors Impacting Drug Delivery Technologies Market
3.7.4 Technological Factors Impacting Drug Delivery Technologies Market
4 COVID-19 Impact: Global Drug Delivery Technologies Market
4.1 Global Drug Delivery Technologies Market Forecast, 2021-2031
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth
5 Global Drug Delivery Technologies Market Size Forecast 2021-2031 by Technology
5.1 Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031
5.1.1 Oral Drug Delivery Therapy is the Largest Revenue Grossing Segment
5.1.2 Recovery Forecasts (V, U, W, L)
5.2 Injectable Drug Delivery Segment: Revenue Forecast 2021-2031
5.2.1 Rising Prevalence of Chronic Diseases is Driving Injectables Segment
5.2.2 Recovery Forecasts (V, U, W, L)
5.3 Topical Drug Delivery Segment: Revenue Forecast 2021-2031
5.3.1 Rising Incidence Of Skin & Tissue Related Illness Bosting the Adoption Of Topical Drugs
5.3.2 Recovery Forecasts (V, U, W, L)
5.4 Pulmonary Drug Delivery Segment: Revenue Forecast 2021-2031
5.4.1 Market For Pulmonary Drug Delivery Is Increasing Due To Innovations In Excipients, Propellants, And Device Technologies
5.4.2 Recovery Forecasts (V, U, W, L)
5.5 Implantable Drug Delivery Segment: Revenue Forecast 2021-2031
5.5.1 Merger Of Implantable Devices With Novel Drug Therapies, Has Considerably Increased
5.5.2 Recovery Forecasts (V, U, W, L)
5.6 Ocular Drug Delivery Segment: Revenue Forecast 2021-2031
5.6.1 Rising Investments In Research & Development
5.6.2 Recovery Forecasts (V, U, W, L)
5.7 Other Drug Delivery Technologies Segment: Revenue Forecast 2021-2031
5.7.1 Adoption Nasal Drug Delivery Technologies is expected to boost the Others Segment Growth
5.7.2 Recovery Forecasts (V, U, W, L)
6 Global Drug Delivery Technologies Market Size Forecast 2021-2031 by Indication
6.1 Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031
6.1.1 Infectious Diseases Therapy is the Largest Revenue Grossing Segment
6.1.2 Recovery Forecasts (V, U, W, L)
6.2 Cancer Segment: Revenue Forecast 2021-2031
6.2.1 Adaptation Of Nanotechnology Has Also Impacted Positively On The Cancer Segment Growth
6.2.2 Recovery Forecasts (V, U, W, L)
6.3 Cardiovascular Diseases Segment: Revenue Forecast 2021-2031
6.3.1 Growing Geriatric Population, Technological Advancements, Coupled With Rising Cardiovascular Illness Are Factors Driving The Growth Of This Segment
6.3.2 Recovery Forecasts (V, U, W, L)
6.4 Diabetes Segment: Revenue Forecast 2021-2031
6.4.1 Technical Advances That Promote The Effective Drug Functioning Coupled With Minimal Administration Of Dosage
6.4.2 Recovery Forecasts (V, U, W, L)
6.5 Respiratory Diseases Segment: Revenue Forecast 2021-2031
6.5.1 Increasing Incidences Of Chronic Respiratory Disorders Is Driving The Respiratory Diseases Segment
6.5.2 Recovery Forecasts (V, U, W, L)
6.6 Central Nervous System Disorders Segment: Revenue Forecast 2021-2031
6.6.1 Public-Private Investments Are Factors Driving The Growth Of CNS Disorders Segment
6.6.2 Recovery Forecasts (V, U, W, L)
6.7 Other Indications Segment: Revenue Forecast 2021-2031
6.7.1 Other Indications Market Is Expected To Grow At A Lucrative CAGR During The Forecast Period
6.7.2 Recovery Forecasts (V, U, W, L)
7 Drug Delivery Technologies Market by End-User Forecast, 2021-2031
7.1 Hospitals Segment Market Forecast, 2021-2031
7.1.1 Hospitals Segment Accounted for the Largest Revenue Share
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Homecare Settings Segment Market Forecast, 2021-2031
7.2.1 Advancement In Portable & Wearable Medical Devices Drives the Homecare Settings Market
7.2.2 Recovery Scenarios (V, U, W, L)
7.3 Other End-User Segment: Revenue Forecast 2021-2031
7.3.1 Increasing Preference for ACS Is Driving The Growth Of This Segment
7.3.2 Recovery Forecasts (V, U, W, L)
8 National Drug Delivery Technologies Market Forecast, 2021-2031
8.1 Global Drug Delivery Technologies Market by Region Forecast 2021-2031
8.1 Recovery Scenarios (V, U, W, L)
9 North America Drug Delivery Technologies Market, 2021-2031
9.1 North America is the Largest Revenue Grossing Region in the Global Market
9.2 North America Drug Delivery Technologies Market by Country, Forecast 2021-2031
9.2.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by Country, 2021-2031
9.3 North America Drug Delivery Technologies Market Forecast by Technology
9.3.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by Technology, 2021-2031
9.4 North America Drug Delivery Technologies Market Forecast by Indication
9.4.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by Indication, 2021-2031
9.5 North America Drug Delivery Technologies Market Forecast by End-User
9.5.1 Recovery Scenarios (V, U, W, L): North America Drug Delivery Technologies Market Forecast by End-User, 2021-2031
9.6 U.S. Drug Delivery Technologies Market Forecast, 2021-2031
9.6.1 Presence of Leading Players is a Major factor driving the U.S. Drug Delivery Technologies Market
9.6.2 Presence of Highly Developed Healthcare Infrastructure
9.6.3 Recovery Scenarios: U.S. Drug Delivery Technologies Market Forecast, 2021-2031
9.7 Canada Drug Delivery Technologies Market Forecast, 2021-2031
9.7.1 Canada Market Anticipated To Witness the Fastest Growth in the North America Region
9.7.2 Growing Research for Drug Delivery Technologies in Canada
9.7.3 Recovery Scenarios: Canada Drug Delivery Technologies Market Forecast, 2021-2031
10 Europe Drug Delivery Technologies Market, 2021-2031
10.1 Second Largest Market in the Global Market
10.2 Europe Drug Delivery Technologies Market by Country, Forecast 2021-2031
10.2.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by Country, 2021-2031
10.3 Europe Drug Delivery Technologies Market Forecast by Technology
10.3.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by Technology, 2021-2031
10.4 Europe Drug Delivery Technologies Market Forecast by Indication
10.4.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by Indication, 2021-2031
10.5 Europe Drug Delivery Technologies Market Forecast by End-User
10.5.1 Recovery Scenarios (V, U, W, L): Europe Drug Delivery Technologies Market Forecast by End-User, 2021-2031
10.6 Germany Drug Delivery Technologies Market Forecast, 2021-2031
10.6.1 Growing Geriatric Population In This Region Is Expected To Boost The Regional Market Growth
10.6.2 Rising Expansion of Pharmaceutical Industry in Germany
10.6.3 Recovery Scenarios: Germany Drug Delivery Technologies Market Forecast, 2021-2031
10.7 UK Drug Delivery Technologies Market Forecast, 2021-2031
10.7.1 Presence of Well-Developed R&D Infrastructure
10.7.2 Rise in Prevalence of Chronic Diseases in the UK
10.7.3 Recovery Scenarios: UK Drug Delivery Technologies Market Forecast, 2021-2031
10.8 France Drug Delivery Technologies Market Forecast, 2021-2031
10.8.1 Growing Demand for Advanced Healthcare Services
10.8.2 Pharmaceutical Companies Looking For Opportunities In The French Market
10.8.3 Recovery Scenarios: France Drug Delivery Technologies Market Forecast, 2021-2031
10.9 Italy Drug Delivery Technologies Market Forecast, 2021-2031
10.9.1 Pharmaceutical Manufacturing Hub
10.9.2 Highly Efficient Healthcare System in Italy is projected to drive the Market Growth
10.9.3 Recovery Scenarios: Italy Drug Delivery Technologies Market Forecast, 2021-2031
10.10 Spain Drug Delivery Technologies Market Forecast, 2021-2031
10.10.1 Demand for Drugs Is Influenced By the Growth of the Pharmaceutical Industry
10.10.2 Spanish Economy Is Growing Strong
10.10.3 Recovery Scenarios: Spain Drug Delivery Technologies Market Forecast, 2021-2031
10.11 Russia Drug Delivery Technologies Market Forecast, 2021-2031
10.11.1 Growing Government Support for the Development of Advanced Cancer Therapies
10.11.2 Unmet Pharmaceutical Needs
10.11.3 Recovery Scenarios: Russia Drug Delivery Technologies Market Forecast, 2021-2031
10.12 Rest of Europe Drug Delivery Technologies Market Forecast, 2021-2031
10.12.1 Increasing Prevalence of Cancer
10.12.2 Recovery Scenarios: Rest of Europe Drug Delivery Technologies Market Forecast, 2021-2031
11 Asia Pacific Drug Delivery Technologies Market, 2021-2031
11.1 Asia Pacific is the Fastest Growing Market
11.2 Asia Pacific Drug Delivery Technologies Market by Country, Forecast 2021-2031
11.2.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2021-2031
11.3 Asia Pacific Drug Delivery Technologies Market Forecast by Technology
11.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by Technology, 2021-2031
11.4 Asia Pacific Drug Delivery Technologies Market Forecast by Indication
11.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by Indication, 2021-2031
11.5 Asia Pacific Drug Delivery Technologies Market Forecast by End-User
11.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Drug Delivery Technologies Market Forecast by End-User, 2021-2031
11.6 Japan Drug Delivery Technologies Market Forecast, 2021-2031
11.6.1 Japan Accounted For the Largest Market Share in the Asia Pacific Region
11.6.2 Supportive Government Policies is Expected to Drive the Market Growth
11.6.3 Recovery Scenarios: Japan Drug Delivery Technologies Market Forecast, 2021-2031
11.7 China Drug Delivery Technologies Market Forecast, 2021-2031
11.7.1 Rising Prevalence of Cancer and Autoimmune Diseases in China expected to Drive the Market Growth
11.7.2 Increasing Healthcare Spending In China
11.7.3 Recovery Scenarios: China Drug Delivery Technologies Market Forecast, 2021-2031
11.8 India Drug Delivery Technologies Market Forecast, 2021-2031
11.8.1 Developing Healthcare Infrastructure
11.8.2 Increasing Prevalence of Cancer
11.8.3 Recovery Scenarios: India Drug Delivery Technologies Market Forecast, 2021-2031
11.9 Australia Drug Delivery Technologies Market Forecast, 2021-2031
11.9.1 Government Programs to Expand Access to Quality Healthcare
11.9.2 Launch of Cell-based Therapies in Australia is Projected to Boost the Market Growth
11.9.3 Recovery Scenarios: Australia Drug Delivery Technologies Market Forecast, 2021-2031
11.10 South Korea Drug Delivery Technologies Market Forecast, 2021-2031
11.10.1 Growing Healthcare Awareness among People
11.10.2 Rising Cancer Incidence is Expected to Drive theSouth Korea Market
11.10.3 Recovery Scenarios: South Korea Drug Delivery Technologies Market Forecast, 2021-2031
11.11 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2021-2031
11.11.1 Rising Disposable Income
11.11.2 Recovery Scenarios: Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2021-2031
12 Latin America Drug Delivery Technologies Market, 2021-2031
12.1 Latin America Drug Delivery Technologies Market
12.2 Latin America Drug Delivery Technologies Market by Country, Forecast 2021-2031
12.2.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by Country, 2021-2031
12.3 Latin America Drug Delivery Technologies Market Forecast by Technology
12.3.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by Technology, 2021-2031
12.4 Latin America Drug Delivery Technologies Market Forecast by Indication
12.4.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by Indication, 2021-2031
12.5 Latin America Drug Delivery Technologies Market Forecast by End-User
12.5.1 Recovery Scenarios (V, U, W, L): Latin America Drug Delivery Technologies Market Forecast by End-User, 2021-2031
12.6 Brazil Drug Delivery Technologies Market Forecast, 2021-2031
12.6.1 Fastest Growing Economy in Latin America
12.6.2 High Potential Manufacturing Environment
12.6.3 Recovery Scenarios: Brazil Drug Delivery Technologies Market Forecast, 2021-2031
12.7 Mexico Drug Delivery Technologies Market Forecast, 2021-2031
12.7.1 Lower Manufacturing Costs than In the US
12.7.2 Strategic Initiatives Undertaken By Market Players
12.7.3 Recovery Scenarios: Mexico Drug Delivery Technologies Market Forecast, 2021-2031
12.8 Rest of Latin America Drug Delivery Technologies Market Forecast, 2021-2031
12.8.1 Evolving Healthcare Infrastructure in Latin America
12.8.2 Recovery Scenarios: Rest of Latin America Drug Delivery Technologies Market Forecast, 2021-2031
13 MEA Drug Delivery Technologies Market, 2021-2031
13.1 Rising Prevalence of Cancer in MEA Region
13.2 MEA Drug Delivery Technologies Market by Country, Forecast 2021-2031
13.2.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by Country, 2021-2031
13.3 MEA Drug Delivery Technologies Market Forecast by Technology
13.3.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by Technology, 2021-2031
13.4 MEA Drug Delivery Technologies Market Forecast by Indication
13.4.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by Indication, 2021-2031
13.5 MEA Drug Delivery Technologies Market Forecast by End-User
13.5.1 Recovery Scenarios (V, U, W, L): MEA Drug Delivery Technologies Market Forecast by End-User, 2021-2031
13.6 South Africa Drug Delivery Technologies Market Forecast, 2021-2031
13.6.1 Prevalence of Chronic Diseases in South Africa is Increasing Rapidly
13.6.2 Polution From Mining Lead to Severe Medical Conditions
13.6.3 Recovery Scenarios: South Africa Drug Delivery Technologies Market Forecast, 2021-2031
13.7 GCC Drug Delivery Technologies Market Forecast, 2021-2031
13.7.1 Presence of Huge Growth Opportunities
13.7.2 Advances in Immuno-Oncology Have Lead In A Paradigm Change
13.7.3 Recovery Scenarios: GCC Drug Delivery Technologies Market Forecast, 2021-2031
13.8 Rest of MEA Drug Delivery Technologies Market Forecast, 2021-2031
13.8.1 Cancer Is One of the Leading Causes of Death in Rest of MEA
13.8.2 Recovery Scenarios: Rest of MEA Drug Delivery Technologies Market Forecast, 2021-2031
14 Company Profiles: Drug Delivery Technologies Market
14.1 Drug Delivery Technologies Market: Company Share Analysis
14.2 Drug Delivery Technologies Market Recent Developments, 2018-2021
14.3 Novartis AG
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2016-2020
14.3.3.2 Business Segments Revenue Shares, 2020
14.3.3.3 Pharmaceuticals Business Unit Revenue Shares, 2020
14.3.3.4 Regional Revenue Shares, 2020
14.3.4 Product Benchmarking
14.3.5 Recent Developments, 2017-2021
14.4 Gilead Sciences, Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2016-2020
14.4.3.2 Business Segments Revenue Shares, 2020
14.4.3.3 Regional Revenue Shares, 2020
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 GlaxoSmithKline plc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Revenue, 2016-2020
14.5.3.2 Pharmaceutical Business Revenue Share, 2020
14.5.3.3 Regional Revenue Shares, 2020
14.5.4 Product Benchmarking
14.5.5 Recent Developments, 2018-2021
14.6 Pfizer Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2016-2020
14.6.3.2 Product Revenue Shares, 2020
14.6.3.3 Regional Revenue Shares, 2020
14.6.4 Product Benchmarking
14.6.5 Recent Developments, 2018-2021
14.7 F. Hoffmann-La Roche Ltd.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2016-2020
14.7.3.2 Product Revenue Shares, 2020
14.7.3.3 Regional Revenue Shares, 2020
14.7.4 Product Benchmarking
14.7.5 Recent Developments, 2018-2021
14.8 Johnson & Johnson
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Revenue, 2016-2020
14.8.3.2 Product Revenue Share, 2020
14.8.3.3 Region Revenue Share, 2020
14.8.4 Product Benchmarking
14.8.5 Recent Developments, 2018-2021
14.9 KINDEVA DRUG DELIVERY
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2016-2020
14.9.4 Product Benchmarking
14.9.5 Recent Developments, 2018-2021
14.10 Eli Lilly and Company
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2016-2020
14.10.4 Product Benchmarking
14.10.5 Recent Developments, 2018-2021
14.11 AstraZeneca
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2016-2020
14.11.3.2 Product Revenue Shares, 2020
14.11.3.3 Regional Revenue Shares, 2020
14.11.4 Product Benchmarking
14.11.5 Recent Developments, 2018-2021
14.12 Boehringer Ingelheim International GmbH
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2016-2020
14.12.3.2 Product Revenue Share, 2020
14.12.3.3 Region Revenue Share, 2020
14.12.4 Product Benchmarking
14.12.5 Recent Developments, 2018-2021
14.13 Amgen Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2016-2020
14.13.4 Product Benchmarking
14.13.5 Recent Developments, 2018-2021
14.14 Bristol-Myers Squibb Company
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2016-2020
14.14.3.2 Regional Revenue Shares, 2020
14.14.4 Product Benchmarking
14.14.5 Recent Developments, 2018-2021
14.15 Sanofi
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2016-2020
14.15.3.2 Product Revenue Share, 2020
14.15.3.3 Region Revenue Share, 2020
14.15.4 Product Benchmarking
14.15.5 Recent Developments, 2018-2021
14.16 Becton, Dickinson and Company
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2016-2020
14.16.3.2 Product Revenue Share, 2020
14.16.3.3 Region Revenue Share, 2020
14.16.4 Product Benchmarking
14.16.5 Recent Developments, 2018-2021
14.17 Bayer AG
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2016-2020
14.17.3.2 Product Revenue Share, 2020
14.17.3.3 Region Revenue Share, 2020
14.17.4 Product Benchmarking
14.17.5 Recent Developments, 2018-2021
15 Conclusion and Recommendations
15.1 Concluding Remarks from
15.2 Recommendations for Market Players
15.3 Leading Regions and Fastest Growing Region (North America Region Accounted for the Largest Market Share)
List of Tables
Table 1 Global Drug Delivery Technologies Market, 2020 & 2031 (US$bn, CAGR %)
Table 2 Major M&A and Collaborations: Drug Delivery Market
Table 3 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031
Table 4 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "V" Shaped Recovery
Table 5 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "U" Shaped Recovery
Table 6 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "W" Shaped Recovery
Table 7 Global Drug Delivery Technologies Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "L" Shaped Recovery
Table 8 Global Drug Delivery Technologies Market Forecast by Technology, 2021-2031 (US$billion, AGR %, CAGR %)
Table 9 Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global Oral Drug Delivery Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 14 Global Injectable Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 15 “V” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 16 “U” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 17 “W” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 18 “L” Shaped Recovery: Global Injectable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 19 Global Topical Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 20 “V” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 21 “U” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 22 “W” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 23 “L” Shaped Recovery: Global Topical Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 24 Global Pulmonary Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 25 “V” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 26 “U” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 27 “W” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 28 “L” Shaped Recovery: Global Pulmonary Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 29 Global Implantable Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 30 “V” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 31 “U” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 32 “W” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 33 “L” Shaped Recovery: Global Implantable Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 34 Global Ocular Drug Delivery Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 35 “V” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 36 “U” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 37 “W” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 38 “L” Shaped Recovery: Global Ocular Drug Delivery Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 39 Global Others Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 40 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 41 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 42 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 43 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 44 Global Drug Delivery Technologies Market Size Forecast by Indication, 2021-2031 (US$billion, AGR %, CAGR %)
Table 45 Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 46 “V” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 47 “U” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 48 “W” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 49 “L” Shaped Recovery: Global Infectious Diseases Therapy Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 50 Global Cancer Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 51 “V” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 52 “U” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 53 “W” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 54 “L” Shaped Recovery: Global Cancer Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 55 Global Cardiovascular Diseases Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 56 “V” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 57 “U” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 58 “W” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 59 “L” Shaped Recovery: Global Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 60 Global Diabetes Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 61 “V” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 62 “U” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 63 “W” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 64 “L” Shaped Recovery: Global Diabetes Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 65 Global Respiratory Diseases Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 66 “V” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 67 “U” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 68 “W” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 69 “L” Shaped Recovery: Global Respiratory Diseases Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 70 Global Central Nervous System Disorders Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 71 “V” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 72 “U” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 73 “W” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 74 “L” Shaped Recovery: Global Central Nervous System Disorders Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 75 Global Other Indications Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 76 “V” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 77 “U” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 78 “W” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 79 “L” Shaped Recovery: Global Other Indications Segment, Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 80 Global Drug Delivery Technologies Market Forecast by End-User, 2021-2031 (US$bn, AGR%, CAGR%)
Table 81 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 82 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Global Hospitals Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%)
Table 87 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 Global Homecare Settings Segment Forecast, 2021-2031 (US$bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 Global Other End-User Segment: Revenue Forecast 2021-2031 (US$billion, AGR%, CAGR%)
Table 92 “V” Shaped Recovery: Global Other End-User Segment, Revenue Forecast 2021-2031 (US
